mTOR activation by cell-extrinsic stimuli, such as by IL-6, VEGF, and insulin-like growth factor-1, also contribute to the disease progression of MM by promoting cell survival, cell metabolism, the cross-talk with the ubiquitin–proteasome system, and angiogenesis [51,52,53,54]. The gene discussed is VEGFA; the disease is Miyoshi myopathy.